05/27/2025
6:40 AM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2025
2:13 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2025
2:15 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2025
2:17 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Schwartz Jonathan David (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2025
2:21 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2025
2:29 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2025
2:32 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2025
2:18 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2025
8:59 AM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025
9:02 AM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
04/30/2025
3:14 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form DEF 14A | |
Get the Latest News and Ratings for RCKTW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/30/2025
3:15 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form DEFA14A | |
04/30/2025
3:16 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form ARS | |
04/22/2025
2:17 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/14/2025
5:57 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2025
4:10 PM | MAVERICK CAPITAL LTD (Filed by)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
04/10/2025
3:07 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
2:26 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/08/2025
3:06 PM | Ondrey Aaron (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2025
4:24 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2025
2:25 PM | Ondrey Aaron (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
3:01 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Schwartz Jonathan David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:01 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2025
11:56 AM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Schwartz Jonathan David (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2025
3:29 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2025
3:09 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2025
3:11 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2025
3:11 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/10/2025
9:25 AM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
02/05/2025
6:47 PM | Pratumsuwan Piratip (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:43 PM | Pratumsuwan Piratip (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/31/2025
2:15 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
8:28 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2025
2:33 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
6:38 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
RTW INVESTMENTS, LP (Reporting)
WONG RODERICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
6:51 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13D/A | |
12/12/2024
5:02 AM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 424B5 | |
11/25/2024
3:05 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Wilson Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:05 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:05 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:05 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
F1 Engineering Powers This Electric Marine Motor (Ad) The future of marine propulsion has arrived - powered by F-1 grade engineering.
In collaboration with McLaren Engineering, a NASDAQ-listed marine tech company unveiled a groundbreaking new electric powertrain set to transform the industry. How one NASDAQ-listed disruptor is bringing the world's most powerful electric marine powertrain to |
11/21/2024
3:26 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2024
3:06 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2024
2:58 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2024
2:27 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
3:15 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
9:52 AM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/07/2024
3:45 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
2:24 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
2:34 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
4:05 PM | Bjork Elisabeth (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:07 PM | Dolsten Mikael (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:05 PM | Dolsten Mikael (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/11/2024
3:06 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
3:26 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Wilson Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
2:29 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
2:39 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
2:16 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
2:23 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024
3:15 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024
3:05 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
2:22 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:05 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
White Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
2:17 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
9:34 AM | Makker Gotham (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4/A | |
